About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6026 record(s)
Req # A-2019-002033
Adverse Reaction Report (AER). Report number: E2B_02691252.Organization: Health Canada
April 2020
Req # A-2019-002079
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_02647196.Organization: Health Canada
April 2020
Req # A-2019-002083
Adverse Reaction Report (AER). Report number: E2B_02699083.Organization: Health Canada
April 2020
Nothing to report this month
Organization: Canada-Nova Scotia Offshore-Petroleum Board
Nothing to report this month
Organization: Financial Transactions and Reports Analysis Centre of Canada
Nothing to report this month
Organization: RCMP External Review Committee
Req # A-2019-00118
Briefing Note : Publication of the Operational brief: Risks and indicators for dealers in precious metals and stonesOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2020
Req # A-2019-00116
Briefing Note : Approval Required for Operational Alert on Vulnerabilities and Risk Mitigation Strategies Related to Money Laundering and Terrorist Activities for Dealers in Precious Metals and Precious StonesOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2020
Req # A-2019-001850
Adverse Reaction Report (AER). Report number: E2B_02781314.Organization: Health Canada
March 2020
Req # A-2015-000172
All documentation regarding the establishment of bioequivalence or therapeutic or clinical equivalence of subsequent-entry inhaled respiratory medication.Organization: Health Canada
March 2020